NTLA
Intellia Therapeutics Inc
12.20$
-1.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -29.2% | 219.1% | -249.9% | -201.3% | -239.5% | -86.1% | -680.8% | -639.4% | -1,086.4% | -602.8% | -515.6% | |
| – | 5.4% | 6.7% | 11.5% | 14.7% | 13.0% | 10.9% | 20.8% | 14.5% | 24.7% | 17.8% | 15.2% | |
| – | 21.6% | 40.7% | 58.7% | 56.0% | 35.0% | 34.3% | 142.2% | 175.4% | 369.5% | 266.6% | 228.0% | |
| – | 21.8% | 40.8% | 59.3% | 56.3% | 35.0% | 34.4% | 138.2% | 329.6% | – | – | – | |
| – | 165.5% | 363.6% | -62.1% | 10.4% | -47.9% | 99.2% | -69.3% | -103.4% | -144.6% | 20.5% | -109.0% | |
| – | 42.3% | 37.4% | 38.6% | 20.9% | 15.8% | 6.2% | 38.6% | 112.0% | 38.6% | 10.0% | 8.5% | |
| – | -42.3% | -37.4% | -38.6% | -856.9% | 58.4% | -369.8% | -1,666.3% | 307.6% | -86.4% | 217.0% | 185.6% | |
| – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | -44.2% | -0.6% | 547.5% | 132.1% | 177.3% | 641.1% | 5,630.4% | 1,118.5% | – | – | – | |
| – | 1,162.9% | 1,015.3% | 547.5% | 132.1% | 177.3% | 641.1% | 2,228.8% | 1,118.5% | 359.3% | 320.9% | 274.5% | |
| – | 1,091.5% | 1,197.0% | 258.9% | -926.0% | -3.8% | 185.2% | -118.4% | 786.6% | -813.5% | -64.9% | -55.5% | |
| – | -71.4% | 181.7% | -288.6% | -222.2% | -255.3% | -92.2% | -719.4% | -751.5% | -1,124.9% | -612.8% | -524.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.